Login / Signup

LI-RADS Treatment Response versus Modified RECIST for Diagnosing Viable Hepatocellular Carcinoma after Locoregional Therapy: A Systematic Review and Meta-Analysis of Comparative Studies.

Dennis Dong Hwan KimBo Hyun KimJoon Il ChoiSoon Nam OhSung Eun Rha
Published in: Taehan Yongsang Uihakhoe chi (2022)
The LR-TR algorithm demonstrated better specificity than mRECIST, without a significant difference in sensitivity for the diagnosis of pathologically viable HCC after LRT.
Keyphrases
  • machine learning
  • deep learning
  • case control
  • ion batteries
  • stem cells
  • neural network
  • structural basis
  • cell therapy
  • bone marrow
  • mesenchymal stem cells
  • smoking cessation